Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 20.40M | $ 15.60M | $ 16.20M | $ 17.10M | $ 18.00M |
Total Assets | $ 765.90M | $ 749.70M | $ 745.60M | $ 746.80M | $ 773.20M |
Total Debt | $ 225.60M | $ 226.60M | $ 229.90M | $ 323.50M | $ 299.50M |
Net Debt | $ 205.20M | $ 211.00M | $ 213.70M | $ 306.40M | $ 281.50M |
Total Liabilities | $ 308.80M | $ 300.50M | $ 304.50M | $ 367.30M | $ 372.10M |
Stockholders Equity | $ 457.10M | $ 449.20M | $ 441.10M | $ 379.50M | $ 401.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |